PTGX

121.4002.11%
AA

Asif Ali

Executive VP & CFO

Mr. Asif Ali has been the Chief Financial Officer and Executive Vice President of Protagonist Therapeutics, Inc. since April 18, 2022. He joined Protagonist Therapeutics, Inc. in April 2022. Prior to joining Protagonist, he served as Vice President of Finance and Chief Accounting Officer for Theravance Biopharma, Inc. from September 2018 to February 2022. Prior to Theravance, Mr. Ali served as Vice President and Corporate Controller for Depomed, Inc. (now Assertio Holdings, Inc.) from June 2012 to June 2018, where he oversaw and contributed to product launches, product acquisitions and financing projects. From 2010 to 2011, he served as Director of Finance and Accounting for Nevada Property 1 LLC. From 2004 to 2009, Mr. Ali worked in public accounting in the life sciences practice of PricewaterhouseCoopers LLP, an accounting firm, where he held various positions of responsibility and left as a Senior Manager. Mr. Ali is a fellow of the Institute of Chartered Accountants in England & Wales, a qualification that he obtained in conjunction with studying accounting at the University of North London, United Kingdom (the combined studies are the U.S. equivalent of a B.S. in Business Administration with concentration in Accounting).

Positions